Anacor Pharmaceuticals to Present at Upcoming Investor Conferences

Anacor Pharmaceuticals to Present at Upcoming Investor Conferences Anacor's first approved drug, KERYDIN® (tavaborole) topical solution, 5%, is an oxaborole antifungal approved by the U.S. Food and Drug Administration in July 2014 for the topical treatment of onychomycosis of the … Continue reading

Posted in Flea Protection Media | Tagged , , , , , | Leave a comment